| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |